Phocas Financial Corp’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.28M	Sell	63,413 -17,907	-22%	-$912K	0.51%	81
2025 Q4	$4.04M	Buy	+81,320	New	+$3.95M	0.53%	77
2025 Q2	–	Sell	-102,550	Closed	-$3.36M	–	155
2025 Q1	$3.36M	Sell	102,550 -5,929	-5%	-$210K	0.51%	82
2024 Q4	$3.92M	Sell	108,479 -981	-0.9%	-$34.5K	0.52%	83
2024 Q3	$3.41K	Sell	109,460 -6,883	-6%	-$215K	0.01%	119
2024 Q2	$3.11K	Sell	116,343 -2,199	-2%	-$63.7K	0.01%	123
2024 Q1	$4.04K	Sell	118,542 -3,017	-2%	-$89.8K	0.02%	113
2023 Q4	$3.52M	Sell	121,559 -35,507	-23%	-$941K	0.46%	96
2023 Q3	$4.33M	Sell	157,066 -150	-0.1%	-$4.57K	0.63%	73
2023 Q2	$4.73M	Sell	157,216 -878	-0.6%	-$30.7K	0.65%	72
2023 Q1	$5.73M	Sell	158,094 -16,852	-10%	-$648K	0.82%	49
2022 Q4	$6.24M	Buy	174,946 +42,348	+32%	+$1.47M	0.9%	41
2022 Q3	$4.49M	Buy	132,598 +26,493	+25%	+$862K	0.7%	65
2022 Q2	$3.07M	Buy	+106,105	New	+$3.04M	0.46%	93